NASDAQ:TRVI
Trevi Therapeutics, Inc.
- Stock
Last Close
11.01
06/11 21:06
Market Cap
186.65M
Beta: 0.69
Volume Today
1.81M
Avg: 82.90K
PE Ratio
−5.22
PFCF: −2.81
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 729.50K - | 1.50M 105.62% | 1.25M 16.70% | 447.50K 64.19% | ||||
average payables | 570K - | 1.10M 93.16% | 1.81M 64.17% | 2.43M 34.58% | 2.85M 17.29% | 2.33M 18.23% | ||
average receivables | 122.50K - | 371K 202.86% | 411.50K 10.92% | 253K 38.52% | 120.50K 52.37% | |||
book value per share | 1.65 - | 1.93 17.11% | 3.06 58.43% | 1.51 50.60% | 0.75 50.52% | 1.66 122.72% | ||
capex per share | -0.00 - | -0.02 1,115.38% | -0.00 97.14% | -0.00 251.14% | -0.00 - | |||
capex to depreciation | -3.25 - | -6.87 111.37% | -0.23 96.64% | -0.68 195.04% | -3.70 - | -1.11 69.88% | ||
capex to operating cash flow | 0.00 - | 0.01 429.92% | 0.00 95.49% | 0.00 183.13% | 0.01 - | 0.00 23.44% | ||
capex to revenue | ||||||||
cash per share | 2.46 - | 1.91 22.05% | 3.21 67.85% | 2.49 22.46% | 1.61 35.29% | 1.87 15.80% | ||
days of inventory on hand | ||||||||
days payables outstanding | ||||||||
days sales outstanding | ||||||||
debt to assets | 0.24 - | 0.01 - | 0.30 4,981.90% | 0.38 26.10% | 0.07 80.38% | 0.01 79.94% | ||
debt to equity | 0.36 - | 0.01 - | 0.52 7,880.93% | 0.86 64.48% | 0.09 90.03% | 0.02 81.02% | ||
dividend yield | 0.03 - | |||||||
earnings yield | -0.18 - | -0.29 59.76% | -0.39 34.11% | -0.75 92.44% | -1.90 153.43% | -0.23 87.68% | ||
enterprise value | 54.00M - | 53.57M 0.80% | 9.92M 81.48% | 12.91M 30.13% | -4.33M 133.57% | 121.15M 2,895.20% | -31.06M 125.64% | |
enterprise value over ebitda | -6.60 - | -2.62 60.32% | -0.37 85.77% | -0.40 6.73% | 0.13 133.26% | -4.05 3,164.75% | 0.92 122.60% | |
ev to operating cash flow | -6.77 - | -2.93 56.75% | -0.43 85.33% | -0.45 3.63% | 0.15 133.63% | -4.30 2,971.69% | 0.98 122.78% | |
ev to sales | ||||||||
free cash flow per share | -0.89 - | -2.06 130.96% | -1.30 37.05% | -1.61 24.11% | -1.27 21.17% | -0.44 65.36% | ||
free cash flow yield | -0.11 - | -0.26 130.96% | -0.35 32.44% | -0.66 92.31% | -1.62 143.88% | -0.23 85.96% | ||
graham net net | 1.63 - | 1.65 1.17% | 2.98 80.05% | 1.43 52.00% | 0.68 52.16% | 1.63 137.93% | ||
graham number | 7.29 - | 9.98 36.78% | 10.03 0.49% | 7.85 21.68% | 5.00 36.33% | 4.11 17.72% | ||
income quality | 0.62 - | 0.89 43.56% | 0.89 0.43% | 0.89 0.14% | 0.85 3.66% | 0.97 13.32% | 1.09 12.88% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -2.46 - | -105.79 4,192.35% | -71.25 - | -27.02 62.08% | -38.34 41.91% | 86.76 326.28% | ||
interest debt per share | 0.96 - | 0.02 97.98% | 0.02 2.85% | 0.81 3,968.74% | 0.69 14.66% | 0.15 77.74% | ||
inventory turnover | ||||||||
invested capital | 0.36 - | 0.01 - | 0.52 7,880.93% | 0.86 64.48% | 0.09 90.03% | 0.02 81.02% | ||
market cap | 70.74M - | 70.74M 0% | 66.88M 5.45% | 43.70M 34.65% | 17.87M 59.12% | 124.57M 597.20% | ||
net current asset value | 14.71M - | 15.61M 6.07% | 54.10M 246.66% | 26.42M 51.16% | 16.56M 37.33% | 107.06M 546.61% | 80.69M 24.63% | |
net debt to ebitda | 2.04 - | 0.84 58.98% | 2.14 154.95% | 0.95 55.67% | 0.68 28.56% | 0.11 83.15% | 0.92 702.76% | |
net income per share | -1.43 - | -2.29 59.76% | -1.46 36.26% | -1.81 24.19% | -1.49 18.08% | -0.45 69.60% | ||
operating cash flow per share | -0.89 - | -2.04 129.35% | -1.29 36.53% | -1.61 24.02% | -1.27 21.08% | -0.44 65.55% | ||
payables turnover | ||||||||
receivables turnover | ||||||||
research and ddevelopement to revenue | ||||||||
return on tangible assets | -0.58 - | -1.00 73.32% | -0.43 56.70% | -0.70 60.09% | -0.88 26.92% | -0.24 73.14% | -0.33 37.19% | |
revenue per share | ||||||||
roe | -0.87 - | -1.19 36.41% | -0.48 59.77% | -1.20 151.41% | -1.99 65.54% | -0.27 86.35% | -0.35 29.79% | |
roic | -0.41 - | -1.06 158.03% | -0.48 54.42% | -0.78 61.40% | -1.02 31.03% | -0.26 74.88% | -0.40 55.30% | |
sales general and administrative to revenue | ||||||||
shareholders equity per share | 1.65 - | 1.93 17.11% | 3.06 58.43% | 1.51 50.60% | 0.75 50.52% | 1.66 122.72% | ||
stock based compensation to revenue | ||||||||
tangible asset value | 14.78M - | 17.31M 17.11% | 54.55M 215.16% | 27.28M 49.98% | 17.07M 37.41% | 107.46M 529.34% | 82.55M 23.18% | |
tangible book value per share | 1.65 - | 1.93 17.11% | 3.06 58.43% | 1.51 50.60% | 0.75 50.52% | 1.66 122.72% | ||
working capital | 15.04M - | 16.11M 7.14% | 54.35M 237.37% | 40.71M 25.09% | 25.23M 38.02% | 109.22M 332.83% | 81.72M 25.17% |
All numbers in USD (except ratios and percentages)